| Archive | |
| |
| 18 September 2006, Volume 95, Number 6 | |
| |
 | |
| Review | back to top |
| |
Combination therapy with aromatase inhibitors: the next era of breast cancer treatment? A Leary & M Dowsett | |
| Abstract | Full Article | PDF |
661 |
| |
| Clinical Studies | back to top |
| |
Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial S Aranda, P Schofield, L Weih, D Milne, P Yates & R Faulkner | |
| Abstract | Full Article | PDF |
667 |
Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA K Charalabopoulos, A Kotsalos, A Batistatou, A Charalabopoulos, P Vezyraki, D Peschos, V Kalfakakou & A Evangelou | |
| Abstract | Full Article | PDF |
674 |
A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B12 in Japanese patients with solid tumours K Nakagawa, S Kudoh, K Matsui, S Negoro, N Yamamoto, J E Latz, S Adachi & M Fukuoka | |
| Abstract | Full Article | PDF |
677 |
Health state utilities for metastatic breast cancer A Lloyd, B Nafees, J Narewska, S Dewilde & J Watkins | |
| Abstract | Full Article | PDF |
683 |
Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable U M Vogl, H Zehetgruber, M Dominkus, M Hejna, C C Zielinski, A Haitel & M Schmidinger | |
| Abstract | Full Article | PDF |
691 |
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis A Maggioni, P Benedetti Panici, T Dell'Anna, F Landoni, A Lissoni, A Pellegrino, R S Rossi, S Chiari, E Campagnutta, S Greggi, R Angioli, N Manci, M Calcagno, G Scambia, R Fossati, I Floriani, V Torri, R Grassi & C Mangioni | |
| Abstract | Full Article | PDF |
699 |
Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial P Michel, A Adenis, F Di Fiore, E Boucher, M P Galais, L Dahan, X Mirabel, H Hamidou, J L Raoul, J H Jacob, M F Hellot, S Prod'Homme & B Paillot | |
| Abstract | Full Article | PDF |
705 |
CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II V Voelter, A Zouhair, H Vuilleumier, M Matter, H Bouzourene, S Leyvraz, J Bauer, P Coucke & R Stupp | |
| Abstract | Full Article | PDF |
710 |
Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial T Seto, S Ushijima, H Yamamoto, K Ito, J Araki, Y Inoue, H Semba & Y Ichinose Kyushu Yamaguchi Thoracic Oncology Group | |
| Abstract | Full Article | PDF |
717 |
| |
| Translational Therapeutics | back to top |
| |
Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126 A Bozec, S Lassalle, J Gugenheim, J-L Fischel, P Formento, P Hofman & G Milano | |
| Abstract | Full Article | PDF |
722 |
A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer S A Veltkamp, B Thijssen, J S Garrigue, G Lambert, F Lallemand, F Binlich, A D R Huitema, B Nuijen, A Nol, J H Beijnen & J H M Schellens | |
| Abstract | Full Article | PDF |
729 |
| |
| Molecular Diagnostics | back to top |
| |
EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer M M S Youssef, P Symonds, I O Ellis & J C Murray | |
| Abstract | Full Article | PDF | Supplementary Information |
735 |
Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer F J G M Kubben, C F M Sier, M J W Meijer, M van den Berg, J J van der Reijden, G Griffioen, C J H van de Velde, C B H W Lamers & H W Verspaget | |
| Abstract | Full Article | PDF |
744 |
| |
| Genetics and Genomics | back to top |
| |
MSH6 germline mutations in early-onset colorectal cancer patients without family history of the disease C Pinto, I Veiga, M Pinheiro, B Mesquita, C Jeronimo, O Sousa, M Fragoso, L Santos, L Moreira-Dias, M Baptista, C Lopes, S Castedo & M R Teixeira | |
| Abstract | Full Article | PDF |
752 |
Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of 'easy to apply' probability models D Bodmer, M J L Ligtenberg, A H van der Hout, S Gloudemans, K Ansink, J C Oosterwijk & N Hoogerbrugge | |
| Abstract | Full Article | PDF | Supplementary Information |
757 |
| |
| Letters to the Editor | back to top |
| |
Controversies on autoimmunity and prognosis in cancer G Ferretti, A Felici & F Cognetti | |
| Abstract | Full Article | PDF |
763 |
Reply: Controversies on autoimmunity and prognosis in cancer T L Whiteside | |
| Abstract | Full Article | PDF |
764 |
| |
| Erratum | back to top |
| |
Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment C Wibom, F Pettersson, M Sjostrom, R Henriksson, M Johansson & A T Bergenheim | |
| Abstract | Full Article | PDF |
766 |
| In this issue | |
| ||
 | Review | |
| Clinical Studies | |
| Translational Therapeutics | |
| Molecular Diagnostics | |
| Genetics and Genomics | |
| Letters to the Editor | |
| Erratum | |
| ||
| ||
| ||
 | Preceding issue | |
 | Next issue | |
| ||
| ||
| ||
|
| ||
| ||
 | ||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2006 Cancer Research UK | ||
| |||
| Privacy Policy | |||